Galmed Pharmaceuticals (GLMD) Invested Capital (2013 - 2025)

Galmed Pharmaceuticals' Invested Capital history runs 12 years deep, the most recent figure standing at $15.8 million for Q4 2025.

• In Q4 2025, Invested Capital fell 3.34% year-over-year to $15.8 million; the TTM figure through Dec 2025 stood at $15.8 million (down 3.34% YoY), while the FY2025 annual figure was $15.8 million, down 3.34% from the prior year.
• Invested Capital was $15.8 million for Q4 2025 at Galmed Pharmaceuticals, down from $16.3 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $30.5 million in Q4 2021 to a low of $13.4 million in Q4 2022.
• Historically, Invested Capital has averaged $18.0 million across 5 years, with a median of $15.8 million in 2025.
• The sharpest annual moves came in 2022 and 2024: Invested Capital plunged 55.99% in 2022, then increased 17.64% in 2024.
• A 5-year view of Invested Capital shows it stood at $30.5 million in 2021, then slumped by 55.99% to $13.4 million in 2022, then gained by 3.4% to $13.9 million in 2023, then increased by 17.64% to $16.3 million in 2024, then slipped by 3.34% to $15.8 million in 2025.
• The last three Invested Capital figures came in at $15.8 million (Q4 2025), $16.3 million (Q4 2024), and $13.9 million (Q4 2023), per Business Quant data.